Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: The DCCT/EDIC study 30-year follow-up

The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group·2016·Diabetes Care

Cited by (712)

Items 401–500 of 712

  1. Investigating the presence and detectability of structural peripheral arterial changes in children with well-regulated type 1 diabetes versus healthy controls using ultra-high frequency ultrasound: a single-centre cross-sectional and case-control study
    Ebba Bergdahl, Gun Forsander, Frida Sundberg, Linda Milkovic, Frida Dangardt · 2025 · EClinicalMedicine
  2. Unravelling the mechanism by which vildagliptin and linagliptin inhibit pyroptosis in lung injury through the NLRP3 inflammatory pathway in type 1 diabetic rats
    Ahmed A. Sedik, Nesma M. E. Abo El-Nasr, Wagdy K. B. Khalil, Aliaa E. M. K. El‐Mosallamy · 2025 · Scientific Reports
  3. Profiled glucose forecasting using genetic programming and clustering
    Sergio Contador, Jose Manuel Velasco, Óscar Garnica, José Ignacio Hidalgo · 2020 · ACM Symposium on Applied Computing
  4. Too Much Dietary Flexibility May Hinder, Not Help: Could More Specific Targets for Daily Food Intake Distribution Promote Glycemic Management among Youth with Type 1 Diabetes?
    Angelica Cristello Sarteau, Elizabeth J. Mayer‐Davis · 2022 · Nutrients
  5. Development and design of the first structured clinic-based program in lower resource settings to transition emerging adults with type 1 diabetes from pediatric to adult care
    Angelica Cristello Sarteau, Ariba Peerzada, Alpesh Goyal, Pradeep A. Praveen, Nikhil Tandon · 2022 · PLOS Global Public Health
  6. Progression of insulin resistance in individuals with type 1 diabetes: A retrospective longitudinal study on individuals from Thailand
    Thanes Jirawatwarakul, Thakorn Pruktanakul, Chaitong Churuangsuk, Warut Aunjitsakul, Wantanee Dangboon Tsutsumi, Rattana Leelawattana, Supamai Soonthornpun, Ramzi Ajjan, Noppadol Kietsiriroje · 2023 · Diabetes and Vascular Disease Research
  7. Role and Perspective of Certified Diabetes Care and Education Specialists in the Development of the 4T Program
    Jeannine C. Leverenz, Brianna Leverenz, Priya Prahalad, Franziska K. Bishop, Piper Sagan, Anjoli Martinez-Singh, Barry Conrad, Annette Chmielewski, Julianne Senaldi, David Scheinker et al. · 2024 · Diabetes Spectrum
  8. A1C: Episode 2
    Nay Linn Aung · 2024 · Clinical Diabetes
  9. Non-coronary arterial outcomes in people with type 1 diabetes mellitus: a Swedish retrospective cohort study
    Tarik Avdic, Björn Eliasson, Araz Rawshani, Jan Borén, Hertzel C. Gerstein, Joakim Nordanstig, Mohamad Rihawi, Joshua A. Beckman, Darren K. McGuire, Elmir Ömerovic et al. · 2024 · The Lancet Regional Health - Europe
  10. Real-world evidence supporting the use of advanced hybrid closed loop in poorly controlled type 1 diabetes patients
    SOPHIE F. GRAF, Giulia Hofer, Ruth Hirschmann, Roger Lehmann, Claudia Cavelti‐Weder · 2025 · Diabetes Research and Clinical Practice
  11. Cumulative exposures to glycaemia and lipids are associated with coronary artery disease in type 1 diabetes: a call for action
    Rebecka Bergdal, Valma Harjutsalo, Per‐Henrik Groop, Stefan Mutter, on behalf of the FinnDiane Study Group · 2025 · Cardiovascular Diabetology
  12. Relationship between Optimum Mini‐doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes – A Simulation Study
    Ajenthen Gayathri Ranjan, Sabrina Lyngbye Wendt, Signe Schmidt, Sten Madsbad, Jens Juul Holst, Henrik Madsen, Carsten Knudsen, John Bagterp Jørgensen, Kirsten Nørgaard · 2017 · Basic & Clinical Pharmacology & Toxicology
  13. Is Continuous Glucose Monitoring Underappreciated in the UK?
    Christopher G. Parkin, Melissa Holloway, Jeffrey Truesdell, Tomas C. Walker · 2017 · touchREVIEWS in Endocrinology
  14. Getting to the Marrow of Trained Immunity
    Laszlo A. Groh, Mihai Gheorghe Netea, Niels Peter Riksen, Samuel T. Keating · 2018 · Epigenomics
  15. Accelerated atherosclerotic cardiovascular risk in type 1 diabetes mellitus: Time for a new idea?
    Ajay Dhanwada Rao, Cherie Lisa Vaz, Kevin Jon Williams · 2019 · Atherosclerosis
  16. Can clustering improve glucose forecasting with genetic programming models?
    Sergio Contador, José Ignacio Hidalgo, Óscar Garnica, Jose Manuel Velasco, Juan Lanchares · 2019 · Genetic and Evolutionary Computation Conference Companion (GECCO Companion)
  17. Emotional distress in patients with type 1 diabetes mellitus
    Joane Viecilli Cechetti, Marcia Khaled Puñales, Luiza Zamprogna Vieira da Cunha, Lilian Rigo · 2020 · Special Care in Dentistry
  18. 13C/12C breath test ratio after the ingestion of a meal naturally enriched with (13C)carbohydrates is a surrogate marker of insulin resistance and insulin sensitivity in children and adolescents with Type 1 Diabetes
    Marco Marigliano, Yves Schütz, Claudia Anita Piona, Francesca Tomasselli, Mara Tommasi, Massimiliano Corradi, Francesca Olivieri, Elena Fornari, Anita Morandi, Claudio Maffeis · 2020 · Diabetes Research and Clinical Practice
  19. Management of Diabetes Mellitus
    Alicia Josephine Jenkins, EMMA S. SCOTT, Jordan Fulcher, Gary Kilov, Andrzej S. Januszewski · 2018 · Contemporary cardiology
  20. Current Treatments on Obesity
    Chul Jin Lee, Min-Jeong Kim, Sang Joon An · 2019 · Daehan imsang geon-gang jeungjin hakoeji/Daehan imsang geon'gang jeungjin haghoeji
  21. What role for metformin in type 1 diabetes?
    2018 · Drug and Therapeutics Bulletin
  22. Improving cardiovascular risk in type 2 diabetes: time to get personal
    Susan V. Gelding · 2016 · European Heart Journal - Quality of Care and Clinical Outcomes
  23. Social and Structural Determinants of Cardiovascular Complications of Diabetes
    PORTIA A. MENSAH, KELLY VALDEZ, Ankita Gyawali, Janet K. Snell‐Bergeon · 2024 · Current Diabetes Reports
  24. Association of continuous subcutaneous insulin therapy and diabetic retinopathy in type 1 diabetes: A national cohort study.
    A. Thykjær, L. Rosengaard, N. Andersen, J. Andresen, J. Hajari, S. Heegaard, K. Højlund, R. Kawasaki, C. Laugesen, S. Möller et al. · 2024 · Journal of diabetes and its complications
  25. Body-weight Cycling and Risk of Diabetic Kidney Disease in People With Type 1 Diabetes in the DCCT/EDIC Population
    Marion Camoin, Kamel Mohammedi, Pierre‐Jean Saulnier, Samy Hadjadj, Jean–François Gautier, Jean‐Pierre Riveline, Nicolas Venteclef, Louis Potier, Gilberto Velho · 2025 · The Journal of Clinical Endocrinology & Metabolism
  26. Glucose Lowering Strategies for Cardiac Benefits: Pathophysiological Mechanisms
    HARPREET SINGH BAJAJ, Bernard Zinman · 2018 · Physiology
  27. Characteristics of people with optimally-managed type 1 diabetes
    Gijsbert Stoet, Richard I. G. Holt · 2023 · Diabetes Epidemiology and Management
  28. Evaluating the impact of differing completion rates of a face‐to‐face DIABETES self‐management education programme on Patient Reported Outcome measures ( DIABETES PRO ): A feasibility trial protocol
    GEMMA A. LEWIS, Greg J Irving, John P.H. Wilding, Kevin J Hardy · 2024 · Diabetic Medicine
  29. Association of fasting blood glucose with in-hospital mortality in acute coronary syndrome patients with different glycemic statuses: Findings from the CCC-ACS project
    Fan Chu, Hangyu Yan, Kehang Lei, Dan Li, Shutong Dong, Yue Zhang, Yutong Cheng, Zhao Li, Zhizhong Li, Haiyan Qian et al. · 2025 · International Journal of Cardiology
  30. An overview of the FreeStyle Libre monitoring system for individuals with type 1 and type 2 diabetes
    Sergio Di Molfetta, Antonio Cutruzzolà, Agostino Gnasso, Concetta Irace · 2025 · Expert Review of Medical Devices
  31. Identification of population characteristics through implementation of the Comprehensive Diabetic Retinopathy Program
    Nish Patel, Lilia Verchinina, Michele Wichorek, Thomas W. Gardner, Dorene S. Markel, Jennifer Wyckoff, Anjali R. Shah · 2019 · Clinical Diabetes and Endocrinology
  32. Update on Diabetes Medical Management: Epidemiology and Treatment
    Lila S Chertman, Danielle Neuman, Francesco Vendrame · 2020 · Springer eBooks
  33. Effects of “metabolic memory” on erectile function in diabetic men: A retrospective case‐control study
    Jialiang Hui, Shisheng Chen, Haibo Zhang, Changmou Yang, Anyang Wei, Shuhua He · 2020 · Andrology
  34. A methods review of posttrial follow-up studies of cardiovascular prevention finds potential biases in estimating legacy effects
    Lin Zhu, Katy Bell, Agnish Nayak, Andrew D. Hayen · 2020 · Journal of Clinical Epidemiology
  35. Hundert Jahre – Insulin bleibt aktuell und notwendig
    Rüdiger Landgraf, Jens Aberle · 2021 · Diabetologie und Stoffwechsel
  36. Drug Resistance in Diabetes
    Adnan Khaliq, Muhammad Farhan Jahangir Chughtai, Javed Iqbal M, Haq Nawaz, Samreen Ahsan, Tariq Mehmood, Atif Liaqat, Muhammad Nadeem, Nimra Sameed, Kanza Saeed et al. · 2021 · Springer eBooks
  37. Cardiovascular Risk Prediction by the American Diabetes Association Risk-Assessment Tool and Novel and Traditional Cardiovascular Risk Factors in Young Adults With Type 1 Diabetes
    Isabel Maria Ramos Inácio, Teresa Azevedo, José Luís Martins, Ana Margarida Balsa, Rosa Dantas, Márcia Alves, Isabel Albuquerque, Joana Guimarães · 2022 · Cureus
  38. Characteristics and outcomes of patients with type 1 diabetes admitted with acute coronary syndromes
    Marcel Maziyar Nejatian, Nick S.R. Lan, Bu Beng Yeap, Girish Dwivedi, P. Gerry Fegan, Abdul Rahman Ihdayhid · 2022 · Diabetes Research and Clinical Practice
  39. A sub-analysis of the SAGE study in Italy indicates good glycemic control in type 1 diabetes
    Daniela Bruttomesso, Concetta Irace, Paolo Pozzilli, Roberto Anichini, Alice Valeria Magiar, Cristiana Maria Baggiore, Olga Disoteo, Antonella Porcu, Enzo Bonora, Maddalena Trombetta et al. · 2022 · Nutrition Metabolism and Cardiovascular Diseases
  40. Type 1 Diabetes and Cardiovascular Health
    Maria Pesantez, Osagie A. Ebekozien, Francesco Vendrame · 2023 · Endocrinology and Metabolism Clinics of North America
  41. Glucose values from the same continuous glucose monitoring sensor significantly differ among readers with different generations of algorithm
    Naru Babaya, Shinsuke Noso, Yoshihisa Hiromine, Yasunori Taketomo, Fumimaru Niwano, Sawa Yoshida, Sara Yasutake, Yumiko Kawabata, Norikazu Maeda, Hiroshi Ikegami · 2024 · Scientific Reports
  42. The Role of Diet in the Prevention and Treatment of Diabetes
    Judith Wylie‐Rosett, Linda M. Delahanty · 2017 · Elsevier eBooks
  43. Optimization of Insulin Regimen and Glucose Outcomes with Short-Term Real-Time Continuous Glucose Monitoring in Adult Type 1 Diabetes Patients with Suboptimal Control on Multiple Daily Injections: The Adult DIACCOR Study
    Sylvie Picard, Hélène P. Hanaire, Yves Reznik, Pierre‐Yves Benhamou, S. Fendri, Lise Dufaitre, Éric Leutenegger, Bruno Guerci · 2018 · Diabetes Technology & Therapeutics
  44. Estimated legacy effects from simulated post-trial data were less biased than from combined trial/post-trial data
    Lin Zhu, Katy Bell, Andrew D. Hayen · 2019 · Journal of Clinical Epidemiology
  45. Customized treatment for Type 1 diabetes patients using novel software
    W. Patrick Zeller, BS Rachel DeGraff, William Zeller · 2020 · Journal of Clinical and Translational Endocrinology Case Reports
  46. The diabetes quality of life brief clinical inventory in combination with the management strategies in type 1 diabetes mellitus with or without the use of insulin pump
    Emmanouil S. Benioudakis, Evangelos D. Georgiou, Eirini Barouxi, Athanasios M. Armagos, Vaia Koutsoumani, Faidra Anastasiou-Veneti, Eleni Koutsoumani, Maria Brokalaki · 2020 · Diabetology International
  47. Center differences in diabetes treatment outcomes among children with type 1 diabetes: A nationwide study of 3866 Danish children
    Niels Skipper, Peter Thingholm, Luise Borch, Amanda Gaulke, Tine Louise Mundbjerg Eriksen, Charlotte Søndergaard, Jannet Svensson · 2021 · Pediatric Diabetes
  48. Role of Continuous Glucose Monitoring in Diabetic Patients at High Cardiovascular Risk: an Expert-based Multidisciplinary Delphi Consensus
    Carlo Di Mario, Stefano Genovese, Gaetano Antonio Lanza, Edoardo Mannucci, Giancarlo Marenzi, Edoardo Sciatti, Dario Pitocco · 2022 · Research Square
  49. Assessing physicians’ agreement and the completeness of the decision aid ‘arriba Diabetes’: a cross-sectional study
    Nicole Lindner, Marie-Christine Hoffmann, Jörg Haasenritter, Jan K. Woike, Norbert Donner‐Banzhoff · 2025 · BMC Family Practice
  50. Cardiovascular risk factors and modern therapeutic strategies in children and adolescents with type 1 diabetes to prevent future diabetic angiopathy in the era of innovative miRNAs biomarkers
    Joanna Peczyńska, Emilia Odyjewska, Kamila Koszykowska, Milena Jamiołkowska‐Sztabkowska, Artur Tadeusz Bossowski, Barbara Głowińska‐Olszewska · 2025 · Frontiers in Endocrinology
  51. The GMI/HbA1c ratio does not independently predict diabetic retinopathy in adults with Type 1 Diabetes
    Carolina Sager-La Ganga, Jose Alfonso Arranz-Martin, Jessica Jiménez-Díaz, Iñigo Hernando-Alday, V. Navas-Moreno, Maria del Mar Fandiño García, G. L. Román Gómez, Jon Garai Hierro, L. E. Lander Lobariñas, Purificación Martínez de Icaya et al. · 2025 · Scientific Reports
  52. Effects of probiotics on blood lipids, glucose and pressure in patients with coronary heart disease: a systematic review and meta-analysis
    Yan Zhong, Xinyu Yang, Weiming Kong, Yaru Shi, WEIXIONG JIAN · 2026 · Frontiers in Cardiovascular Medicine
  53. Toward continuous and non-invasive monitoring: a scoping review of in vitro blood glucose devices from electrochemistry to optics and micro-system integration
    wanmeng wang, Chongyu Liu, Peiwen Lin, Suo Li, Yongchao Yao, Zhuqing Wang, Walter W. Hu · 2026 · Journal of Materials Chemistry B
  54. Glucose Control and Continuous Glucose Monitoring Metrics During 12 Months of Treatment with Tirzepatide in Overweight or Obese Patients with Type 1 Diabetes
    Halis Kaan Aktürk, Kagan Ege Karakus, Dicle Cengiz, Emma Mason, Elizabeth Beck, Gurleen Kaur, Satish K. Garg · 2026 · Diabetes Technology & Therapeutics
  55. Relationship Between Glycosylated Hemoglobin Variability and the Severity of Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus
    Xinyan Liu, Xiyao Yang, Na Wu · 2024 · Journal of Diabetes Research
  56. Building a Diabetes Educator Program for Remote Patient Monitoring Billing
    Franziska K. Bishop, Annette Chmielewski, Jeannine C. Leverenz, Shannon Lin, Barry Conrad, Anjoli Martinez-Singh, Laura Pike, David Scheinker, Priya Prahalad, David M. Maahs · 2024 · Journal of Diabetes Science and Technology
  57. Impact of type 1 diabetes mellitus on mortality rate and outcome of hospitalized patients with myocardial infarction
    Volker H. Schmitt, Lukas Hobohm, Omar Hahad, Visvakanth Sivanathan, Frank Patrick Schmidt, Thomas F. Münzel, Philipp C. Lurz, Tommaso Gori, Karsten Keller · 2025 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  58. Antidiabetic Drugs Consumption in France Over a Decade: An Observational Study
    David De Bandt, Johanna Mezence, Claire Rives‐Lange, Dominik Menges, Claire Carette · 2025 · Clinical Therapeutics
  59. Revisiting the benefits vs risk profile of sodium-glucose co-transporter inhibitor use in type 1 diabetes Part A: Benefits of sodium-glucose co-transporter inhibitor use in type 1 diabetes
    Jennifer Ngan, David Norman O'Neal, Melissa H. Lee, Yee Wen Kong, Richard J. MacIsaac · 2025 · Diabetes Research and Clinical Practice
  60. Glycated hemoglobin is not enough: The role of glycemia risk index for glycemic control assessment in type 1 diabetes
    Binbin He, Zi-Zhu Liu, Ruo-Yao Xu, Fan Li, Rui Guo, Chao Deng, Yuting Xie, Zhiguang Zhou, Xia Li · 2025 · World Journal of Diabetes
  61. Ernährungstherapie bei Diabetes
    Anja Bosy‐Westphal, Friederike Fieres-Keller, Manfred James Müller · 2017 · Diabetologie und Stoffwechsel
  62. Procoagulant activity in children and adolescents on intensive insulin therapy
    Vibeke Bratseth, Hanna Dis Margeirsdottir, Martin Heier, Svein Solheim, Harald Arnesen, Knut Dahl‐Jørgensen, Ingebjørg Seljeflot · 2020 · Pediatric Diabetes
  63. Improving Diabetes Control Using Lean Six Sigma Quality Improvement in an Endocrine Clinic in a Large Accountable Care Organization
    Usha Kollipara, Mario Carlos C Rivera Bernuy, Joseph Putra, Jessica Burks, Amber Meyer, Shayla Ferguson, Carolyn Nelson, Jackie Mutz, Sasan Mirfakhraee, Puneet Bajaj et al. · 2020 · Clinical Diabetes
  64. Sexual dimorphism in response to repetitive bouts of acute aerobic exercise in rodents with type 1 diabetes mellitus
    Jordan C. Larocque, Silar Gardy, Mitchell J. Sammut, David P. McBey, C.W. James Melling · 2022 · PLoS ONE
  65. Intensified follow-up of patients with type 1 diabetes and poor glycaemic control: a multicentre quality improvement collaborative based on data from the Norwegian Diabetes Register for Adults
    Tone Vonheim Madsen, John G. Cooper, Siri Carlsen, Karianne Fjeld Løvaas, Magne Rekdal, Jannicke Igland, Sverre Sandberg, Grethe Åstrøm Ueland, Marjolein M. Iversen, Una Ørvim Sølvik · 2023 · BMJ Open Quality
  66. Fast-Acting Insulin Aspart in Patients with Type 1 Diabetes in Real-World Clinical Practice: A Noninterventional, Retrospective Chart and Database Study
    Marcus Lind, Sergiu‐Bogdan Catrina, Neda Rajamand Ekberg, Sofia Gerward, Tariq Halasa, Jarl Hellman, Detlef Hess, Magnus Löndahl, Veronica Qvist, Jan Bolinder · 2023 · Diabetes Therapy
  67. Hypoglycemia does not affect the progression of preclinical atherosclerosis in subjects with type 2 diabetes
    Concetta Irace, Antonio Cutruzzolà, Delia Francesca Carbotti, Simona Mastroianni, Michela Cavallo, Agostino Gnasso · 2019 · PLoS ONE
  68. Targeting postprandial glycaemia in children with diabetes: O pportunities and challenges
    Myfanwy C. Geyer, Christopher Keith Rayner, Michael Horowitz, Jennifer Couper · 2017 · Diabetes Obesity and Metabolism
  69. Introduction to SMBG
    Darja Šmigoc Schweiger, Tadej Battelino · 2020 · Elsevier eBooks
  70. Simultaneous pancreas-kidney transplantation
    Irene Mosca, Edward J. Sharples, Sanjay Sinha, Peter John Friend · 2019 · Elsevier eBooks
  71. Comment on Echouffo-Tcheugui et al. Visit-to-Visit Glycemic Variability and Risks of Cardiovascular Events and All-Cause Mortality: The ALLHAT Study. Diabetes Care 2019;42:486–493
    Louis Monnier, C Colette, David R. Owens · 2019 · Diabetes Care
  72. Biomarkers and Precision Medicine in Diabetes
    Sok Cin Tye, Michele Provenzano, Hiddo J.L. Heerspink · 2024
  73. Diabetic Macular Edema in the Western Part of Romania: Screening to Improve Patient Outcomes
    Adriana Ivanescu, Simona Daniela Popescu, Deiana Roman, Monica Desiree Dragomir, Romulus Zorin Timar · 2025 · Journal of Personalized Medicine
  74. Impact of the era of diabetes onset in a national care system on the prevalence of retinopathy and microalbuminuria in people living with type 1 diabetes 15 years post‐diagnosis: A cross‐sectional, real‐world observational study
    Astrid Lavens, Christophe E.M. De Block, Philippe Oriot, Jean‐Christophe Philips, Michel Vandenbroucke, Laurent Crenier, Frank R. E. Nobels, Chantal Mathieu, the Belgian Group of Experts IQED · 2025 · Diabetes Obesity and Metabolism
  75. A multi-stakeholder perspective on medical devices for children and adolescents with type 1 diabetes: huge unmet needs for the smallest
    Torben Biester, Felix Reschke, Thomas Danne, Marc Julien, Irja Lutsar, Katharine Y Cheng, Maria Cavaller-Bellaubi, Michelle Katz, E. Niemöller, Éric Renard et al. · 2025 · Journal of Pediatric Endocrinology and Metabolism
  76. Advances and future perspectives in the treatment and prognosis of type 1 diabetes mellitus
    Yuqing Fu, Jun Zeng, Qian He · 2025 · Frontiers in Clinical Diabetes and Healthcare
  77. Differences Between Glycemia Estimates from Hemoglobin A1c and Continuous Glucose Monitoring and Their Association with Complete Blood Counts
    Veronica Tozzo, David M. Nathan, Heidi J Krause-Steinrauf, John M. Lachin, Mary E. Larkin, Christopher Mow, Nicole M. Butera, Robert M. Cohen, John M. Higgins · 2025 · Diabetes Technology & Therapeutics
  78. Impact of coexisting diabetes on the development of cardiovascular disease and death in patients with cancer
    Yoshihiro Kuwabara, Toshitaka Morishima, Haruka Kudo, Mizuki Shimadzu Kato, Shihoko Koyama, Kayo Nakata, Isao Miyashiro · 2026 · PLoS ONE
  79. School-partnered collaborative care intervention for young children with type 1 diabetes: A pilot and feasibility protocol
    Christine A. March, Scott Rothenberger, Elissa Naame, VICTORIA STOUFFER, Christine Moon, Aaron R. Lyon, Ingrid M. Libman, Elizabeth C. Miller · 2026 · Contemporary Clinical Trials
  80. Heart Failure in Type 1 vs. Type 2 Diabetes Mellitus: Shared Pathways, Distinct Challenges
    M S Hussain, Saraswathi Iyer, Y J Liew, Mya Lelt Win, Rory J. McCrimmon, Chim Choy Lang, Ify R. Mordi · 2026 · Journal of Diabetes Research
  81. Diabetic Retinopathy Outcomes and Early Worsening of Diabetic Retinopathy in Adolescents and Young Adults With Type 1 Diabetes Following Rapid and Large Glycemic Improvements After Commencing Automated Insulin Delivery
    Wipa Warunyuwong, Alisa Boucsein, Kate M. B. Sneddon, Francesc March de Ribot, Mary-Jane Sime, Y Zhou, Tom Wilkinson, Martin I. de Bock, Esko J. Wiltshire, Ryan G. Paul et al. · 2026 · Journal of Diabetes Science and Technology
  82. Metabolic Complications of Home Parenteral Nutrition and Short Bowel Syndrome
    Manpreet S. Mundi, Aravind Reddy Kuchkuntla, Ryan T. Hurt · 2018 · Elsevier eBooks
  83. Prevalence of LDL-hypercholesterolemia and other cardiovascular risk factors in young people with type 1 diabetes
    Irena Drozd, Jantje Weiskorn, Karin Lange, Torben Biester, Nicolin Datz, Kerstin Kapitzke, Felix Reschke, Thekla von dem Berge, Jürgen Weidemann, Thomas Danne et al. · 2023 · Journal of clinical lipidology
  84. Insulin Treatment of Diabetes Mellitus-Tight vs. Conventional Control
    Nicholas Emanuele, Peter D. Reaven · 2023 · Contemporary cardiology
  85. Screening of lipids and kidney function in children and adolescents with Type 1 Diabetes: does age matter?
    Eulalia Catamo, Antonietta Robino, Klemen Dovč, Davide Tinti, Gianluca Tamaro, Riccardo Bonfanti, Roberto Franceschi, Ivana Rabbone, Tadej Battelino, Gianluca Tornese · 2023 · Frontiers in Endocrinology
  86. Soluble urokinase plasminogen activator receptor, platelet aggregation, and carotid plaque thickness in diabetes: A cross-sectional analysis
    Viktor Rotbain Curovic, Juliette Tavenier, Luis Felipe Ferreira-Divino, Christina Poulsen, Morten Baltzer Houlind, Oliver Buchhave Pedersen, Lærke Urbak, Tine W. Hansen, Henrik Hegaard Sillesen, Marie Frimodt‐Møller et al. · 2023 · Journal of Diabetes and its Complications
  87. Early increase in carotid intima-media thickness in women with childhood-onset type 1 diabetes compared with healthy peers: the Norwegian Atherosclerosis and Childhood Diabetes study
    Aida Simeunovic, Cathrine Brunborg, Martin Heier, Tore Julsrud Berg, Knut Dahl‐Jørgensen, Hanna Dis Margeirsdottir · 2025 · BMJ Open Diabetes Research & Care
  88. Admission Glucose Number (AGN): A Point of Admission Score Associated With Inpatient Glucose Variability, Hypoglycemia, and Mortality
    Jennifer McKechnie, Rahat Maitland, Christopher A. R. Sainsbury, Gregory C. Jones · 2018 · Journal of Diabetes Science and Technology
  89. Pathogenesis of Microvascular Complications
    Mogher Khamaisi, George Liang King, Kyoungmin Park, Qian Li · 2020 · Endocrinology
  90. Novel Drugs for Diabetes Also Have Dramatic Benefits on Hard Outcomes of Heart and Kidney Disease
    Michael C. Y. Chan, Jonathan C.H. Chan · 2022 · Current Cardiology Reviews
  91. Audit of the dietetic care of patients with type 1 diabetes at a large Australian paediatric tertiary hospital and comparison with the International Society for Paediatric and Adolescent Diabetes nutrition guidelines
    Rachel Battersby, Annabel Sweeney, Sarah Toome, Janice M. Fairchild, Jacqueline M. Miller · 2016 · Nutrition & Dietetics
  92. Dipeptidyl peptidase‐4 inhibitor approaches
    Zachary T. Bloomgarden · 2016 · Journal of Diabetes
  93. Antihyperglycemic agents and cardiovascular outcomes
    HARPREET SINGH BAJAJ, Bernard Zinman, Subodh Verma · 2017 · Current Opinion in Cardiology
  94. Ernährungstherapie bei Diabetes
    Anja Bosy‐Westphal, Friederike Fieres-Keller, Manfred James Müller · 2017 · Aktuelle Ernährungsmedizin
  95. Intensive glucose control in patients with diabetes prevents onset and progression of microalbuminuria, but effects on end-stage kidney disease are still uncertain
    Clement Lo, Sophia Zoungas · 2017 · BMJ Evidence-Based Medicine
  96. Effect of background insulin therapy on cardiovascular outcomes with SGLT-2 inhibitors in type 2 diabetes: A meta-analysis of cardiovascular outcome trials
    Awadhesh Kumar Singh, Ritu Singh · 2021 · Diabetes Research and Clinical Practice
  97. Les variabilités « métaboliques » : fluctuations aiguës et ondulations lentes, causes et conséquences
    Louis Monnier, C Colette · 2022 · Médecine des Maladies Métaboliques
  98. The OPTIMISE study protocol: a multicentre optimisation trial comparing continuous glucose monitoring, snacking habits, sleep extension and values-guided self-care interventions to improve glucose time-in-range in young people (13–20 years) with type 1 diabetes
    Shelley Rose, Jillian Joy Haszard, Barbara C. Galland, Esko J. Wiltshire, Martin I. de Bock, Carmel E. Smart, Miriama Ketu-McKenzie, Anna Campbell, Ruth Thomson, Craig Jefferies et al. · 2022 · Journal of Diabetes & Metabolic Disorders
  99. Conquering diabetes therapeutic inertia: practical tips for primary care
    Joy Moverley, Lucia M. Novak, Jay H. Shubrook · 2022 · Journal of Osteopathic Medicine
  100. Variability in benefit from intensive insulin therapy on cardiovascular events in individuals with type 1 diabetes: A post hoc analysis of the DCCT / EDIC study
    Marga A. G. Helmink, Steven H J Hageman, Frank L.J. Visseren, Wendela L. de Ranitz‐Greven, Harold W. de Valk, Thomas T. van Sloten, Jan Westerink · 2023 · Diabetic Medicine